December 20, 2019
Rose
The North American trade pact is moving swiftly through Congress. The legislation is noticeably missing a provision that would have granted market exclusivity for biologics for 10 years. The removal of the protection was a big win for Democrats and a huge loss for the pharmaceutical industry. In other news: an Ebola vaccine, nerve drugs, biotech stocks, a subscription model for medication, and more.
from Kaiser Health News https://ift.tt/35GH9k5
December 20, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Feds Move to Rein In Prior Authorization, a System That Harms and Frustrates Patients- Seniors With Anxiety Frequently Don’t Get Help. Here’s Why.
- Why Does Insulin Cost So Much? Big Pharma Isn’t the Only Player Driving Prices
- Pacientes negros visten elegante y hablan distinto para evitar prejuicios cuando van al médico
- Por qué los adultos mayores con ansiedad suelen no recibir ayuda
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment